Stopped early

ROSA® Hip System THA PMCF

NCT05497206 · Zimmer Biomet · Updated 13 Oct 2026

What is being tested: One of the following hip implants may be used within this arm of the study: G7 Acetabular System, Taperloc Complete System, Avenir and Avenir Complete Systems, and Echo Bi-Metric System
For: Osteoarthritis, Hip; Avascular Necrosis of Hip
Kind of study: Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join: Ages 18 years to 80 years. About 12 people. The full rules are on the registry page.
Where: United States (2 sites)
When: Starts or started 5 June 2024, ends 20 Dec 2024. Registered 11 Aug 2022.
Results: None posted yet.

In the researchers' words

This study is a Prospective, Multicenter, Single-Arm, Cohort post-market study to evaluate the accuracy of acetabular implant position using the robotic-arm surgical assistant (ROSA® Hip System).

ClinicalTrials.gov, NCT05497206

Sites

The Mayo Clinic JacksonvilleJacksonville, Florida, United States
Mosaic Life CareSaint Joseph, Missouri, United States